GlassScriptPhysician profile
John W Swartz
NPI 1215166913
$3,437.81
in general payments reported to CMS, 2019-2025
9 companies · $58.32 in 2025
The $58.32 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $993 · 2020: $233 · 2022: $329 · 2023: $1,563 · 2024: $261 · 2025: $58.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,296 · Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,295.88 |
| Food and Beverage | $586.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,683.83 | 2019-2024 | Arcos, Rosa, Persona |
| Stryker Corporation | $488.86 | 2020-2025 | Mako, Variax, T2 Alpha |
| Depuy Synthes Sales INC. | $67.77 | 2019 | |
| Abbott Laboratories | $45.39 | 2024-2025 | Proclaim |
| Heraeus Medical, LLC. | $39.18 | 2019-2020 | |
| Smith+Nephew, INC. | $38.40 | 2022-2024 | Pico |
| Convatec INC. | $32.64 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $24.92 | 2022 | |
| Medtronic USA, INC. | $16.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Swartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.